# Clinical Trial of Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults

> **NCT04962308** · PHASE4 · UNKNOWN · sponsor: **Sinovac Research and Development Co., Ltd.** · enrollment: 1400 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** SARS-CoV-2 Inactivated Vaccine
- **BIOLOGICAL:** The SARS-CoV-2 Inactivated Vaccine

## Key facts

- **NCT ID:** NCT04962308
- **Lead sponsor:** Sinovac Research and Development Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-19
- **Primary completion:** 2021-08-19
- **Final completion:** 2021-12-19
- **Target enrollment:** 1400 (ESTIMATED)
- **Last updated:** 2021-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04962308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04962308, "Clinical Trial of Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04962308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*